Sudeep Pharma Ltd

Integrated Filing — Corporate Governance (NSE XBRL)

Company Home Dashboard NSE Viewer

Filing Summary

Company
Sudeep Pharma Limited
Symbol
SUDEEPPHRM
Quarter Ended
31-Mar-2026
Submission
New

General Disclosures

Advertisements As Per Regulation471
Yes
Annual Return As Provided Under Section92Of The Companies Act2013
Yes
Approval For Material Related Party Transactions
Yes
Approval Of The Board And Shareholders For Compensation Or Profit Sharing
Yes
Audio Or Video Recordings And Transcripts Of Post Earinings Or Quarterly Calls
Yes
Board Composition
Yes
Code Of Conduct
Yes
Compliance Certificate
Yes
Compliance With Sub Regulation3Of Regulation46With Respect To Accuracy Of Disclosures On The Website And Timely Updation
Yes
Confirmation That The Disclosures Are In A Separate Section As Specified In Sub Regulation2Of Regulation46
Yes
Credit Rating Or Revision In Credit Rating Obtained
Not Applicable
Date Of End Of Financial Year
31-Mar-2026
Date Of End Of Reporting Period
31-Mar-2026
Date Of Signing
29-Apr-2026
Date Of Start Of Financial Year
01-Apr-2025
Designation Of Person
Company Secretary and Compliance Officer
Designation Of Person Affirmations
Company Secretary and Compliance Officer
Designation Of Person For Annual Affirmations
Company Secretary and Compliance Officer
Designation Of Person For Quartely Affirmations
Company Secretary and Compliance Officer
Details Of Agreements Entered Into With The Media Companies And Or Their Associates
Not Applicable
Details Of Business
Yes
Details Of Establishment Of Vigil Mechanism Or Whistle Blower Policy
Yes
Disclosure Of Contact Details Of KMP Who Are Authorized For The Purpose Of Determining Materiality Under Sub Regulation5Of Regulation30
Yes
Disclosure Of Related Party Transactions On Consolidated Basis
Yes
Disclosure Web Link Of Annual Return As Provided Under Section92Of The Companies Act2013Is Placed
https://www.sudeeppharma.com/investor-relations/annual-reports/#annual-returns
Disclosure Web Link Of Audio Or Video Recordings And Transcripts Of Post Earinings Or Quarterly Calls Is Placed
https://www.sudeeppharma.com/investor-relations/financial-results/#concall-audio
Disclosure Web Link Of Company At Advertisements As Per Regulation471Is Placed
https://www.sudeeppharma.com/investor-relations/financial-results/#press-release
Disclosure Web Link Of Company At Dividend Distribution Policy As Per Regulation43A1Is Placed
https://www.sudeeppharma.com/wp-content/uploads/2025/06/Distribution-of-Dividend-Policy.pdf
Disclosure Web Link Of Company At Materiality Policy As Per Sub Regulation4Regulation30Is Placed
https://www.sudeeppharma.com/wp-content/uploads/2025/11/Materiality-Policy-2.pdf
Disclosure Web Link Of Company At Separate Audited Financial Statements Of Each Subsidiary Of The Listed Entity Is Placed
https://www.sudeeppharma.com/investor-relations/annual-reports/#subsidiary-financials
Disclosure Web Link Of Company At Which Details Of Business Is Placed
https://www.sudeeppharma.com/
Disclosure Web Link Of Company At Which Details Of Establishment Of Vigil Mechanism Or Whistle Blower Policy Is Placed
https://www.sudeeppharma.com/wp-content/uploads/2025/06/Vigil-Mechanisum-Policy.pdf
Disclosure Web Link Of Company At Which Financial Results Is Placed
https://www.sudeeppharma.com/investor-relations/financial-results/
Disclosure Web Link Of Company At Which Policy For Determining Material Subsidiaries Is Placed
https://www.sudeeppharma.com/wp-content/uploads/2025/12/h-POLICY-ON-MATERIAL-SUBSIDIARY.pdf
Disclosure Web Link Of Company At Which Policy On Dealing With Related Party Transactions Is Placed
https://www.sudeeppharma.com/wp-content/uploads/2025/06/Materiality-of-related-Party-Transactions-and-Manner-of-Dealing-with-Related-party-Transactions.pdf
Disclosure Web Link Of Company At Which Shareholding Pattern Is Placed
https://www.sudeeppharma.com/investor-relations/corporate-governance/#reports-and-filings-with-stock-exchange
Disclosure Web Link Of Compliance With Sub Regulation3Of Regulation46With Respect To Accuracy Of Disclosures On The Website And Timely Updation Is Placed
https://www.sudeeppharma.com/investor-relations/disclosure-under-regulation-46/
Disclosure Web Link Of Confirmation That The Disclosures Are In A Separate Section As Specified In Sub Regulation2Of Regulation46Is Placed
https://www.sudeeppharma.com/investor-relations/disclosure-under-regulation-46/
Disclosure Web Link Of Disclosure Of Contact Details Of KMP Who Are Authorized For The Purpose Of Determining Materiality Under Sub Regulation5Of Regulation30Is Placed
https://www.sudeeppharma.com/disclosure-of-contact-details-of-key-managerial-personnel/
Disclosure Web Link Of Disclosures Under Sub Regulation8Of Regulation30Is Placed
https://www.sudeeppharma.com/investor-relations/corporate-governance/#reports-and-filings-with-stock-exchange
Disclosure Web Link Of Employee Benefit Scheme Documents Framed In Terms Of SEBI Share Based Employee Benefits And Sweat Equity Regulations2021Is Placed
https://www.sudeeppharma.com/wp-content/uploads/2026/04/Amended-ESOP-Policy-17.06.2025.pdf
Disclosure Web Link Of Memorandum Of Association And Articles Of Association Is Placed
https://www.sudeeppharma.com/investor-relations/corporate-governance/#memorandum-of-association-and-articles-of-association
Disclosure Web Link Of Schedule Of Analyst Or Institutional Investor Meet And Presentation Prepared By Listed Entity For Analyst Or Institutional Investor Meet Is Placed
https://www.sudeeppharma.com/investor-relations/financial-results/#concall-invitation https://www.sudeeppharma.com/investor-relations/financial-results/#investor-presentations
Disclosure Web Link Of Secretarial Compliance Report Is Placed
https://www.sudeeppharma.com/investor-relations/corporate-governance/#reports-and-filings-with-stock-exchange
Disclosures Under Sub Regulation8Of Regulation30
Yes
Dividend Distribution Policy As Per Regulation43A1
Yes
Employee Benefit Scheme Documents Framed In Terms Of SEBI Share Based Employee Benefits And Sweat Equity Regulations2021
Yes
Fees Or Compensation
Yes
Financial Results
Yes
Is SCORESID Available
Yes
ISIN
INE0QPI01025
Market Capitalisation As Per Immediate Previous Financial Year
Top 1000 listed entities
Materiality Policy As Per Sub Regulation4Regulation30
Yes
Memorandum Of Association And Articles Of Association
Yes
Minimum Information
Yes
MSEI Symbol
NOTLISTED
Name Of Signatory
Dimple Mehta
Name Of Signatory Affirmations
Dimple Mehta
Name Of Signatory For Annual Affirmations
Dimple Mehta
Name Of Signatory For Quartely Affirmations
Dimple Mehta
Name Of The Company
SUDEEP PHARMA LIMITED
New Name And The Old Name Of The Listed Entity
Not Applicable
Other Corporate Governance Requirements With Respect To Subsidiary Of Listed Entity
Yes
Place
Vadodara
Plans For Orderly Succession For Appointments
Yes
Policy For Determining Material Subsidiaries
Yes
Policy For Related Party Transaction
Yes
Policy On Dealing With Related Party Transactions
Yes
Reason For Part F Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Loans Or Guarantees Or Comfort Letters Or Securities Etc Is Not Applicable To The Entity
There is no acquisition of shares during the quarter
Recommendation Of Board
Yes
Reporting Quarter
Yearly
Review Of Compliance Reports
Yes
Risk Assessment And Management
Yes
Schedule Of Analyst Or Institutional Investor Meet And Presentation Prepared By Listed Entity For Analyst Or Institutional Investor Meet
Yes
SCORES Registration ID
coms2207
Scrip Code
544619
Secretarial Compliance Report
Yes
Separate Audited Financial Statements Of Each Subsidiary Of The Listed Entity
Yes
Shareholding Pattern
Yes
Statements Of Deviations Or Variations As Specified In Regulation32
Not Applicable
Symbol
SUDEEPPHRM
The Listed Entity Has Approved Material Subsidiary Policy And The Corporate Governance Requirements With Respect To Subsidiary Of Listed Entity Have Been Complied
Yes
Type Of Company
Equity
Type Of Submission
Original
Vacancies In Respect Key Managerial Personnel
Yes
Vigil Mechanism
Yes
Whether As Per Sub Regulation2ba Of Regulation27Of SEBILODR There Has Been Cyber Security Incidents During The Quarter
No
Whether Part A Of Annexure I Of The SEBI Circular Dated31December2024Related To Compliance Report On Corporate Governance Is Applicable To The Entity
Yes
Whether Part F Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Loans Or Guarantees Or Comfort Letters Or Securities Etc Is Applicable To The Entity
No

Additional Disclosures

Entry D_MeetingBOD1
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingBOD2
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingBOD3
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingBOD4
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingBOD5
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingBOD6
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit1
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit10
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit11
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit2
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit3
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit4
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit5
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit6
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit7
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit8
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit9
Whether Requirement Of Quorum Met
Yes
Official NSE disclosure viewer

If the viewer does not load, use the NSE Viewer button above to open it in a new tab.

Board Composition — Entity Disclosures

The Composition Of Board Of Directors Is In Terms Of Sebi Regulations2015
Yes
Chairperson Related to MD / CEO
No
Regular Chairperson
Yes

Composition of Board of Directors

SrTitleDirectorPANDINCategory 1Category 2Date of BirthDisqualifiedStatusSpecial ResolutionInitial AppointmentRe-appointmentTenure (months)Listed DirectorshipsIndependent DirectorshipsAudit / Stakeholder MembershipsAudit / Stakeholder Chair Posts
1MrSHANIL SUJIT BHAYANI******08877823Executive DirectorNot Applicable29-Dec-1992NoActiveNot Applicable10-Dec-202101-Jan-2025151010
2MrBHAYANI SUJIT JAYSUKH******01767427Executive DirectorChairperson28-Nov-1967NoActiveNot Applicable01-Mar-199501-Jan-2025151020
3MrAJAY SHRIRANG KANDELKAR******10773491Executive DirectorNot Applicable09-Oct-1975NoActiveNot Applicable13-Sep-202413-Sep-2024191000
4MrSAMARESH PARIDA******01853823Non-Executive - Independent DirectorNot Applicable01-Sep-1960NoActiveNot Applicable13-Sep-202413-Sep-2024193343
5MrRAGHUNANDAN SATHYANARAYAN RAO******02263845Non-Executive - Independent DirectorNot Applicable12-Mar-1965NoActiveNot Applicable13-Sep-202413-Sep-2024191110
6MsRESHMA SURESH PATEL******00165162Non-Executive - Independent DirectorNot Applicable11-Dec-1960NoActiveNot Applicable13-Sep-202413-Sep-2024192230
7MrSUJIT GULATI******00177274Non-Executive - Independent DirectorNot Applicable22-Nov-1959NoActiveNot Applicable13-Sep-202413-Sep-2024193362

Committee Disclosures

Entry CompComit122
Date of Appointment
26-Oct-2024
Entry CompComit123
Date of Appointment
26-Oct-2024
Entry CompComit124
Date of Appointment
26-Oct-2024
Entry CompComit14
Date of Appointment
26-Oct-2024
Entry CompComit15
Date of Appointment
26-Oct-2024
Entry CompComit16
Date of Appointment
26-Oct-2024
Entry CompComit41
Date of Appointment
26-Oct-2024
Entry CompComit42
Date of Appointment
26-Oct-2024
Entry CompComit43
Date of Appointment
17-Jun-2025
Entry CompComit68
Date of Appointment
26-Oct-2024
Entry CompComit69
Date of Appointment
26-Oct-2024
Entry CompComit70
Date of Appointment
26-Oct-2024
Entry CompComit71
Date of Appointment
26-Oct-2024
Entry CompComit95
Date of Appointment
26-Oct-2024
Entry CompComit96
Date of Appointment
26-Oct-2024
Entry CompComit97
Date of Appointment
26-Oct-2024
Entry CompComit98
Date of Appointment
26-Oct-2024
Entry MainD
Composition And Role Of Risk Management Committee
Yes
Composition Of Audit Committee
Yes
Composition Of Nomination And Remuneration Committee
Yes
Composition Of Stakeholder Relationship Committee
Yes
Composition Of Various Committees Of Board Of Directors
Yes
Disclosure Web Link Of Company At Which Composition Of Various Committees Of Board Of Directors Is Placed
https://www.sudeeppharma.com/kmp-smp-and-committee/
Memberships In Committees
Yes
Prior Or Omnibus Approval Of Audit Committee For All Related Party Transactions
Yes
Risk Management Committee
Yes
Role Of Audit Committee And Information To Be Reviewed By The Audit Committee
Yes
Role Of Nomination And Remuneration Committee
Yes
Role Of Stakeholders Relationship Committee
Yes
The Committee Members Have Been Made Aware Of Their Powers Role And Responsibilities As Specified In Sebi Regulations2015
Yes
The Composition Of Audit Committee Is In Terms Of Sebi Regulations2015
Yes
The Composition Of The Nomination And Remuneration Committee Is In Terms Of Sebi Regulations2015
Yes
The Composition Of The Risk Management Committee Is In Terms Of Sebi Regulations2015
Yes
The Composition Of The Stakeholders Relationship Committee Committee Is In Terms Of Sebi Regulations2015
Yes
Whether The Audit Committee Has A Regular Chairperson
Yes
Whether The Corporate Social Responsibility Committee Has A Regular Chairperson
Yes
Whether The Nomination And Remuneration Committee Has A Regular Chairperson
Yes
Whether The Risk Management Committee Has A Regular Chairperson
Yes
Whether The Stakeholders Relationship Committee Has A Regular Chairperson
Yes

Audit Committee

Additional Position
Chairperson
Director DIN
01853823
Member Name
SAMARESH PARIDA
Position
Non-Executive - Independent Director

Audit Committee

Additional Position
Member
Director DIN
00165162
Member Name
RESHMA SURESH PATEL
Position
Non-Executive - Independent Director

Audit Committee

Additional Position
Member
Director DIN
01767427
Member Name
SUJIT JAYSUKH BHAYANI
Position
Executive Director

Audit Committee

Audit Committee

Audit Committee

Corporate Social Responsibility Committee

Additional Position
Chairperson
Director DIN
01767427
Member Name
SUJIT JAYSUKH BHAYANI
Position
Executive Director

Corporate Social Responsibility Committee

Additional Position
Member
Director DIN
08877823
Member Name
SHANIL SUJIT BHAYANI
Position
Executive Director

Corporate Social Responsibility Committee

Additional Position
Member
Director DIN
00165162
Member Name
RESHMA SURESH PATEL
Position
Non-Executive - Independent Director

Corporate Social Responsibility Committee

Nomination and remuneration committee

Additional Position
Chairperson
Director DIN
00165162
Member Name
RESHMA SURESH PATEL
Position
Non-Executive - Independent Director

Nomination and remuneration committee

Additional Position
Member
Director DIN
01853823
Member Name
SAMARESH PARIDA
Position
Non-Executive - Independent Director

Nomination and remuneration committee

Additional Position
Member
Director DIN
00177274
Member Name
SUJIT GULATI
Position
Non-Executive - Independent Director

Nomination and remuneration committee

Other Committee

Additional Position
Chairperson
Director DIN
01767427
Member Name
SUJIT JAYSUKH BHAYANI
Name Of Other Committee
IPO Committee
Position
Executive Director

Other Committee

Additional Position
Member
Director DIN
08877823
Member Name
SHANIL SUJIT BHAYANI
Name Of Other Committee
IPO Committee
Position
Executive Director

Other Committee

Additional Position
Member
Director DIN
01853823
Member Name
SAMARESH PARIDA
Name Of Other Committee
IPO Committee
Position
Non-Executive - Independent Director

Other Committee

Name Of Other Committee
IPO Committee

Other Committee

Name Of Other Committee
IPO Committee

Other Committee

Name Of Other Committee
IPO Committee

Risk Management Committee

Additional Position
Chairperson
Director DIN
02263845
Member Name
RAGHUNANDAN SATHYANARAYAN RAO
Position
Non-Executive - Independent Director

Risk Management Committee

Additional Position
Member
Director DIN
01767427
Member Name
SUJIT JAYSUKH BHAYANI
Position
Executive Director

Risk Management Committee

Additional Position
Member
Director DIN
08877823
Member Name
SHANIL SUJIT BHAYANI
Position
Executive Director

Risk Management Committee

Additional Position
Member
Director DIN
00177274
Member Name
SUJIT GULATI
Position
Non-Executive - Independent Director

Risk Management Committee

Risk Management Committee

Stakeholders Relationship Committee

Additional Position
Chairperson
Director DIN
00177274
Member Name
SUJIT GULATI
Position
Non-Executive - Independent Director

Stakeholders Relationship Committee

Additional Position
Member
Director DIN
02263845
Member Name
RAGHUNANDAN SATHYANARAYAN RAO
Position
Non-Executive - Independent Director

Stakeholders Relationship Committee

Additional Position
Member
Director DIN
01767427
Member Name
SUJIT JAYSUKH BHAYANI
Position
Executive Director

Stakeholders Relationship Committee

Additional Position
Member
Director DIN
08877823
Member Name
SHANIL SUJIT BHAYANI
Position
Executive Director

Stakeholders Relationship Committee

Entry MainD
Gap Between The Meetings Of The Risk Management Committee
Yes
Meeting Of Audit Committee
Yes
Meeting Of Board Of Directors
Yes
Meeting Of Independent Directors
Yes
Meeting Of Nomination And Remuneration Committee
Yes
Meeting Of Risk Management Committee
Yes
Meeting Of Stakeholders Relationship Committee
Yes
Quorum Of Board Meeting
Yes
Quorum Of Nomination And Remuneration Committee Meeting
Yes
Quorum Of Risk Management Committeemeeting
Yes
The Meetings Of The Board Of Directors And The Above Committees Have Been Conducted In The Manner As Specified In Sebi Regulations2015
Yes
Entry MeetingBOD1
Dates Of Meeting In The Previous Quarter
15-Oct-2025
Number Of Directors Present In Meeting Of Board Of Directors
7
Number Of Independent Directors Attending The Meeting
4
Total Number Of Directors As On Date Of The Meeting
7
Entry MeetingBOD2
Dates Of Meeting In The Previous Quarter
27-Oct-2025
Maximum Gap Between Any Two Consecutive Meetings
11
Number Of Directors Present In Meeting Of Board Of Directors
7
Number Of Independent Directors Attending The Meeting
4
Total Number Of Directors As On Date Of The Meeting
7
Entry MeetingBOD3
Dates Of Meeting In The Previous Quarter
15-Nov-2025
Maximum Gap Between Any Two Consecutive Meetings
18
Number Of Directors Present In Meeting Of Board Of Directors
7
Number Of Independent Directors Attending The Meeting
4
Total Number Of Directors As On Date Of The Meeting
7
Entry MeetingBOD4
Dates Of Meeting In The Previous Quarter
25-Nov-2025
Maximum Gap Between Any Two Consecutive Meetings
9
Number Of Directors Present In Meeting Of Board Of Directors
7
Number Of Independent Directors Attending The Meeting
4
Total Number Of Directors As On Date Of The Meeting
7
Entry MeetingBOD5
Dates Of Meeting In The Previous Quarter
19-Dec-2025
Maximum Gap Between Any Two Consecutive Meetings
23
Number Of Directors Present In Meeting Of Board Of Directors
7
Number Of Independent Directors Attending The Meeting
4
Total Number Of Directors As On Date Of The Meeting
7
Entry MeetingBOD6
Dates Of Meeting If Any In The Relevant Quarter
06-Feb-2026
Maximum Gap Between Any Two Consecutive Meetings
48
Number Of Directors Present In Meeting Of Board Of Directors
7
Number Of Independent Directors Attending The Meeting
4
Total Number Of Directors As On Date Of The Meeting
7
Entry MeetingComit1
Dates Of Meeting Of The Committee In The Previous Quarter
27-Oct-2025
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
3
Number Of Independent Director Attending Meeting Of Committee
2
Number Of Member Attending Meeting Of Committee
4
Total Number Of Directors As On Date Of The Meeting
3
Entry MeetingComit10
Dates Of Meeting Of The Committee In The Previous Quarter
26-Nov-2025
Maximum Gap Between Any Two Consecutive Meetings
5
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
3
Number Of Independent Director Attending Meeting Of Committee
1
Number Of Member Attending Meeting Of Committee
3
Total Number Of Directors As On Date Of The Meeting
3
Entry MeetingComit11
Dates Of Meeting Of The Committee In The Relevant Quarter
06-Feb-2026
Maximum Gap Between Any Two Consecutive Meetings
71
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
4
Number Of Independent Director Attending Meeting Of Committee
2
Number Of Member Attending Meeting Of Committee
4
Total Number Of Directors As On Date Of The Meeting
4
Entry MeetingComit2
Dates Of Meeting Of The Committee In The Previous Quarter
18-Dec-2025
Maximum Gap Between Any Two Consecutive Meetings
51
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
3
Number Of Independent Director Attending Meeting Of Committee
2
Number Of Member Attending Meeting Of Committee
4
Total Number Of Directors As On Date Of The Meeting
3
Entry MeetingComit3
Dates Of Meeting Of The Committee In The Relevant Quarter
06-Feb-2026
Maximum Gap Between Any Two Consecutive Meetings
49
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
3
Number Of Independent Director Attending Meeting Of Committee
2
Number Of Member Attending Meeting Of Committee
4
Total Number Of Directors As On Date Of The Meeting
3
Entry MeetingComit4
Dates Of Meeting Of The Committee In The Previous Quarter
19-Dec-2025
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
3
Number Of Independent Director Attending Meeting Of Committee
1
Number Of Member Attending Meeting Of Committee
5
Total Number Of Directors As On Date Of The Meeting
3
Entry MeetingComit5
Dates Of Meeting Of The Committee In The Previous Quarter
27-Oct-2025
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
3
Number Of Independent Director Attending Meeting Of Committee
3
Number Of Member Attending Meeting Of Committee
1
Total Number Of Directors As On Date Of The Meeting
3
Entry MeetingComit6
Dates Of Meeting Of The Committee In The Previous Quarter
17-Oct-2025
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
4
Number Of Independent Director Attending Meeting Of Committee
2
Number Of Member Attending Meeting Of Committee
3
Total Number Of Directors As On Date Of The Meeting
4
Entry MeetingComit7
Dates Of Meeting Of The Committee In The Relevant Quarter
06-Feb-2026
Maximum Gap Between Any Two Consecutive Meetings
111
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
4
Number Of Independent Director Attending Meeting Of Committee
2
Number Of Member Attending Meeting Of Committee
4
Total Number Of Directors As On Date Of The Meeting
4
Entry MeetingComit8
Dates Of Meeting Of The Committee In The Previous Quarter
17-Nov-2025
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
3
Number Of Independent Director Attending Meeting Of Committee
1
Number Of Member Attending Meeting Of Committee
4
Total Number Of Directors As On Date Of The Meeting
3
Entry MeetingComit9
Dates Of Meeting Of The Committee In The Previous Quarter
20-Nov-2025
Maximum Gap Between Any Two Consecutive Meetings
2
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
3
Number Of Independent Director Attending Meeting Of Committee
1
Number Of Member Attending Meeting Of Committee
4
Total Number Of Directors As On Date Of The Meeting
3
Entry MainD
Contact Information Of The Designated Officials Of The Listed Entity Who Are Responsible For Assisting And Handling Investor Grievances
Yes
Disclosure Web Link Of Company At Which Contact Information Of The Designated Officials Of The Listed Entity Who Are Responsible For Assisting And Handling Investor Grievances Is Placed
https://www.sudeeppharma.com/disclosure-of-contact-details-of-key-managerial-personnel/
Disclosure Web Link Of Company At Which Email Address For Grievance Redressal And Other Relevant Details Is Placed
https://www.sudeeppharma.com/investor-relations/investor-contact/
Email Address For Grievance Redressal And Other Relevant Details
Yes
No Of Investor Complaints Disposed Off During The Period
6
No Of Investor Complaints During The Period
-2
No Of Investor Complaints Received During The Period
4
Whether Part B Of Annexure I Of The SEBI Circular Dated31December2024Related To Investor Grievance Redressal Report Is Applicable To The Entity
Yes
Entry MainI
No Of Investor Complaints
0
Entry PY_I
No Of Investor Complaints
2
Composition Of Board Of Directors Of Unlisted Material Subsidiary
Yes
Reason For Part C Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Acquisition Of Shares Or Voting Rights In Unlisted Companies Is Not Applicable To The Entity
There is no acquisition of shares during the quarter
Whether Part C Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Acquisition Of Shares Or Voting Rights In Unlisted Companies Is Applicable To The Entity
No
Entry I_OngoingTaxLitigationsOrDisputes1
Current Status
The Company (Sudeep Pharma Limited) has filed Appeal, against OIO no. DEM/02/SUPDT/R-I/DIV-I/2025-26 dated 22.12.2025, on 23.03.2026 and after that no further notice or communication has been received. The Amount involved in the matter is INR 11,02,353/- only. This matter is relating to FY 2018-19 and FY 2019-20.
Date of Initiation
22-Dec-2025
Opposing Party
Office of Supritendent Central GST & Central Excise, Vadodara
Status (Previous Disclosure)
Ongoing
Entry MainD
Whether Part E Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Updates To Ongoing Tax Litigations Or Disputes Is Applicable To The Entity
Yes
Reason For Part D Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Imposition Of Fine Or Penalty Is Not Applicable To The Entity
There is no acquisition of shares during the quarter
Whether Part D Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Imposition Of Fine Or Penalty Is Applicable To The Entity
No